Israel Diabetes Care Devices Market Outlook to 2016

Summary

GlobalData’s medical device report offering, “Israel Diabetes Care Devices Market Outlook to 2016” provides key market data on the Israel diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. This medical equipment report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price ($) data for each of the segments and sub-segments within two market categories.
- Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Israel diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Israel diabetes care devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices In Israel 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Israel, Overall Revenue ($m), 2002-2016 11
3.3 Diabetes Care Devices Market, Israel, Revenue Mix ($m), 2009 12
3.4 Diabetes Care Devices Market, Israel, Category Contribution (%), 2009 13
3.5 Diabetes Care Devices, Israel, Category Volume (Units), 2002-2016 17
3.6 Diabetes Care Devices, Israel, Company Share (2008-2009) 20
4 Glucose Monitoring In Israel 22
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, Israel, Revenue Mix ($m), 2009 23
4.3 Glucose Monitoring Market, Israel, Category Contribution (%), 2009 24
4.4 Glucose Monitoring Overall Revenue (2002-2016) 25
4.5 Glucose Monitoring Overall Volume (2002-2016) 27
4.6 Glucose Monitoring Average Price (2002-2016) 29
4.7 Glucose Monitoring Distribution Share (2008-2009) 30
4.8 Glucose Monitoring, Israel, Company Share (2008-2009) 31
5 Insulin Delivery In Israel 33
5.1 Insulin Delivery, Market Segmentation 33
5.2 Insulin Delivery Market, Israel, Revenue Mix ($m), 2009 34
5.3 Insulin Delivery Market, Israel, Category Contribution (%), 2009 35
5.4 Insulin Delivery Overall Revenue (2002-2016) 36
5.4.1 Insulin Pens Revenue (2002-2016) 39
5.5 Insulin Delivery Overall Volume (2002-2016) 41
5.5.1 Insulin Pens Revenue (2002-2016) 43
5.6 Insulin Delivery Average Price (2002-2016) 45
5.7 Insulin Delivery Distribution Share (2008-2009) 46
5.8 Insulin Delivery, Israel, Company Share (2008-2009) 47
6 Overview of Key Companies in Israel Diabetes Care Devices Market 49
6.1 Novo Nordisk A/S 49
6.1.1 Company Overview 49
6.1.2 Share in the Israel Diabetes Care Devices Market 49
6.2 Sanofi-Aventis 50
6.2.1 Company Overview 50
6.2.2 Share in the Israel Diabetes Care Devices Market 50
6.3 F. Hoffmann-La Roche Ltd. 51
6.3.1 Company Overview 51
6.3.2 Share in the Israel Diabetes Care Devices Market 51
6.4 Eli Lilly and Company 52
6.4.1 Company Overview 52
6.4.2 Share in the Israel Diabetes Care Devices Market 52
6.5 Becton, Dickinson and Company 53
6.5.1 Company Overview 53
6.5.2 Share in the Israel Diabetes Care Devices Market 53
6.6 Bayer HealthCare AG 54
6.6.1 Company Overview 54
6.6.2 Share in the Israel Diabetes Care Devices Market 54
6.7 LifeScan, Inc. 55
6.7.1 Company Overview 55
6.7.2 Share in the Israel Diabetes Care Devices Market 55
6.8 Medtronic, Inc. 56
6.8.1 Company Overview 56
6.8.2 Share in the Israel Diabetes Care Devices Market 56
6.9 B. Braun Melsungen AG 57
6.9.1 Company Overview 57
6.10 Abbott Laboratories 57
6.10.1 Company Overview 57
6.11 Smiths Medical 57
6.11.1 Company Overview 57
6.12 Terumo Corporation 58
6.12.1 Company Overview 58
6.13 ARKRAY, Inc. 58
6.13.1 Company Overview 58
6.14 Apex Biotechnology Corp. 59
6.14.1 Company Overview 59
6.15 Animas Corporation 59
6.15.1 Company Overview 59
6.16 Medingo Ltd. 59
6.16.1 Company Overview 59
6.17 Beta-O2 Technologies Ltd. 59
6.17.1 Company Overview 59
6.18 G-Sense Ltd. 60
6.18.1 Company Overview 60
6.19 Integrity Applications Ltd. 60
6.19.1 Company Overview 60
6.20 InsuLine Medical Ltd. 60
6.20.1 Company Overview 60
7 Diabetes Care Devices Market Pipeline Products 61
8 Financial Deals Landscape 64
8.1 Acquisition 64
8.1.1 Roche Holding to Acquire Medingo from Elron Electronic Industries 64
9 Appendix 66
9.1 Definitions of Markets Covered in the Report 67
9.1.1 Diabetes Care Devices 67
9.2 Research Methodology 69
9.3 Secondary Research 70
9.4 Primary Research 70
9.5 Models 71
9.6 Forecasts 71
9.7 Expert Panels 71
9.8 GlobalData Consulting 71
9.9 Currency Conversion 72
9.10 Contact Us 72
9.11 Disclaimer 72